Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Zomedica's shares outstanding was 980M at Jun 30, 2026. For fiscal 2025 it was 980M, up 0.0% from the year before. The highest annual figure on record is 980M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 980M | 0.0% |
| FY2024 | Dec 31, 2024 | 980M | 0.0% |
| FY2023 | Dec 31, 2023 | 980M | 0.0% |
| FY2022 | Dec 31, 2022 | 980M | +2.4% |
| FY2021 | Dec 31, 2021 | 957M | +162.5% |
| FY2020 | Dec 31, 2020 | 364M | +242.9% |
| FY2019 | Dec 31, 2019 | 106M | +13.8% |
| FY2018 | Dec 31, 2018 | 93M | +6.9% |
| FY2017 | Dec 31, 2017 | 87M | +9.0% |
| FY2016 | Dec 31, 2016 | 80M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 980M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 980M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | 980M | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | 980M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 980M | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | 980M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | 980M | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | 980M | 0.0% |
| Q2 FY2024 | Jun 30, 2024 | 980M | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | 980M | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | 980M | 0.0% |
| Q3 FY2023 | Sep 30, 2023 | 980M | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | 980M | +0.0% |
| Q1 FY2023 | Mar 31, 2023 | 980M | +0.0% |
| Q4 FY2022 | Dec 31, 2022 | 980M | -0.0% |
| Q3 FY2022 | Sep 30, 2022 | 980M | +0.1% |
| Q2 FY2022 | Jun 30, 2022 | 980M | +0.6% |
| Q1 FY2022 | Mar 31, 2022 | 980M | +10.1% |
| Q4 FY2021 | Dec 31, 2021 | 980M | +67.9% |
| Q3 FY2021 | Sep 30, 2021 | 978M | +77.7% |
| Q2 FY2021 | Jun 30, 2021 | 974M | +353.2% |
| Q1 FY2021 | Mar 31, 2021 | 890M | +652.3% |
| Q4 FY2020 | Dec 31, 2020 | 584M | +440.3% |
| Q3 FY2020 | Sep 30, 2020 | 551M | +409.6% |
| Q2 FY2020 | Jun 30, 2020 | 215M | +98.8% |
| Q1 FY2020 | Mar 31, 2020 | 118M | +17.3% |
| Q4 FY2019 | Dec 31, 2019 | 108M | +12.4% |
| Q3 FY2019 | Sep 30, 2019 | 108M | +14.3% |
| Q2 FY2019 | Jun 30, 2019 | 108M | +16.8% |
| Q1 FY2019 | Mar 31, 2019 | 101M | +11.4% |
| Q4 FY2018 | Dec 31, 2018 | 96M | +7.5% |
| Q3 FY2018 | Sep 30, 2018 | 95M | +6.4% |
| Q2 FY2018 | Jun 30, 2018 | 93M | +6.3% |
| Q1 FY2018 | Mar 31, 2018 | 91M | +7.2% |
| Q4 FY2017 | Dec 31, 2017 | 89M | – |
| Q3 FY2017 | Sep 30, 2017 | 89M | – |
| Q2 FY2017 | Jun 30, 2017 | 87M | – |
| Q1 FY2017 | Mar 31, 2017 | 84M | – |
See a number that looks wrong?